4-methyl-5-(1H-pyrrol-1-yl)nicotinic acid, 95.0%, 500mg

2,4-Difluorobenzenesulfonamide, 98.0%, 100g

3-Phenyloxetan-3-ol, 95.0%, 5g

K 858>98.0%(HPLC)(qNMR)25mg

1-(2-Bromo-4-chloro-phenyl)-2,2,2-trifluoro-ethanol, 95%, 250mg

(2E)-1-(2-chlorophenyl)-3-(3-methylthiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

(S)-2-(Morpholin-2-yl)acetic acid, 97%, 250mg

Ambroxol Hydrochloride, 97.0%, 25g

Methyl 2-fluoroacrylate (stabilised with 1% BHT), 96.0%, 1g

(R)-1-(3-(Trifluoromethyl)phenyl)ethanamine, 96.0%, 250mg

7-Bromo-2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine, 98%, 500mg

Báscula de precisión serie EHA, 0,1 g, 1000 g, EHA 1000-1

3-(3-methoxy-4-nitrophenyl)-9-methyl-3,9-diazaspiro[5.5]undecane, 95.0%, 100mg